Advertisement
Advertisement
U.S. markets open in 9 hours 3 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Milestone Pharmaceuticals Inc. (MIST)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.60-0.02 (-0.26%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close7.62
Open7.74
Bid6.68 x 1000
Ask8.37 x 900
Day's Range7.33 - 7.92
52 Week Range5.09 - 9.03
Volume68,534
Avg. Volume40,427
Market Cap227.031M
Beta (5Y Monthly)3.60
PE Ratio (TTM)N/A
EPS (TTM)-0.85
Earnings DateMar 28, 2022 - Apr 01, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.60
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for MIST

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Milestone Pharmaceuticals Inc.
    Analyst Report: Bristol-Myers Squibb CompanyBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
    Rating
    Fair Value
    Economic Moat
    2 months agoMorningstar
View more
Advertisement
Advertisement